Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19167838 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Conditions: Brain Cancer;   Recurrent Malignant Gliomas;   Primary Brain Tumor
Intervention: Other: bevacizumab and radiation (IMRT)
2 Recruiting Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Condition: Non GIST Sarcomas
Intervention: Drug: sunitinib

Indicates status has not been verified in more than two years